Company Profile - DOD BIOTECH PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 28 August 2022 21:45 Company Profile DOD BIOTECH PUBLIC COMPANY LIMITED Please
TISCO ASSET MANAGEMENT COMPANY LIMITED|Feeder Fund ,Sector Fund | Offering Date : 02/03/2020 - 11/03/2020
Acquisition of Assets of DOD Biotech Public Company Limited regarding the Acquisition of Land and Establishment of Subsidiary, which is Class 2 Transaction (Schedule 1) DOD Biotech Public Company Limited ( the
could not be verified. As a result, it is uncertain that the 154 million baht fund quoted in the tender offer would be adequate. The tender offeror and the financial advisor must demonstrate with
containing the COVID-19, economic growth is forecasted to contract by -7.8%1; the lowest growth among ASEAN countries. In addition, a range of political issues are loading to an uncertain economic recovery
uncertain as conditions stated under Expected transaction date have to be achieved first. Therefore, the Company will calculate the value of the transaction and will inform the Stock Exchange of Thailand and
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
Assets by Subsidiary of DOD Biotech Public Company Limited for the Purchase and Acceptance of Transfer of the Entire Business of BGP Spectrum Power Co., Ltd., and Establishment of Subsidiary, Classified as
information on 26 November 2019. In this regard, the issuance and the offering of the newly-issued ordinary shares to the existing shareholders are uncertain until an approval from the Extraordinary General
is on May 7, 2018. However, the entitlement to receive the dividend is uncertain because it has yet to be approved by the shareholders. 2. Approved the proposed initial public offering of new ordinary